- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Add on Estradiol to 2% minoxidil offers no additional advantage in Female pattern hair loss, suggests study
A new study published in the Clinical and Experimental Dermatology journal showed that estradiol with minoxidil (EMX) may raise the risk of irregular menstruation in individuals with female pattern hair loss (FPHL) which is also known as female androgenetic alopecia (AGA). The variables that influence miniature follicle development and the pathophysiology of FPHL are yet unknown. There is proof that genetic, hormonal, and environmental factors also play a part in male AGA, in addition to the most obvious impact of androgens. Women who have thick, healthy hair are more likely to feel secure, confident, and capable of change. They are also more likely to engage with others.
The prevalence of female pattern hair loss is high and has a detrimental effect on one's quality of life. The most effective treatment for FPHL is minoxidil, however it is more difficult to treat than male pattern hair loss. Several trials treated FPHL with 17α-estradiol solution, either by alone or in combination with minoxidil, with varying degrees of success. Thus, this study evaluated the safety and effectiveness of topical 17α-estradiol 0.01% with minoxidil 2% against minoxidil 2% in the treatment of FPHL, by Nermeen Ibrahim Bedair and colleagues.
For this study, 43 women with FPHL were instructed to apply a spray-on solution comprising either 17α-estradiol 0.01% plus minoxidil 2% (EMX group) or minoxidil 2% alone (MX group) blindfolded twice a day. The course of treatment lasted six months. After baseline and after the conclusion of the therapy, trichoscopic and clinical evaluations were conducted.
Both groups displayed indicators of improvement at the conclusion of the therapy session. The EMX group outperformed the MX group in terms of improvement metrics, however, this difference was not statistically significant. Menstrual abnormalities were more common among the patients of EMX group. Overall, the findings of this study suggest that a 0.01% 17α-estradiol and 2% minoxidil solution does not appear to provide a statistically significant benefit over minoxidil alone, and there may be a greater chance of related menstrual abnormalities in the treatment of FPHL.
Reference:
Bedair, N. I., EL-Komy, M. H. M., Mohamed, R. E., Shamma, R. N., & Amer, M. A. (2024). Efficacy and safety of combined topical ethinylestradiol with minoxidil versus topical minoxidil in female pattern hair loss. A trichoscopic randomized controlled clinical study. In Clinical and Experimental Dermatology. Oxford University Press (OUP). https://doi.org/10.1093/ced/llae436
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751